GE Healthcare installs purification tech at FujiFilm Diosynth site

By Staff reporter

- Last updated on GMT

FujiFilm Diosynth site in Billingham (source FujiFilm Diosynth)
FujiFilm Diosynth site in Billingham (source FujiFilm Diosynth)

Related tags: Biotechnology

GE Healthcare has completed another tech installation at FujiFilm Diosynth’s biopharmaceuticals facility in Billingham, UK, integrating a single-use purification system with bioreactors it provided in 2014.

The project – which involved integrating an AKTA purification system with bioreactors installed at the facility a few years back​ – was completed in just over a year according to a GE spokeswoman, who told us the timescale fitted Fujifilm need to increase capacity.

“The objective was to duplicate​ and mirror​ FujiFilm’s existing production capacity in North Carolina, USA to Billingham” she said, adding that the contract manufacturing organization (CMO) had seen an increase in demand from customers with drugs in trials.

FujiFilm Diosynth needed a solution that would allow them to quickly turnaround larger numbers of smaller batches. The key was to create the right capacity for their customers that is both flexible and efficient​.”

The project was not a full-blown “FlexFactory” - which is GE’s bespoke modular plant technologies that have recently adopted by firms like BeiGene​, Gallus​, JHL Biotech​ and Nanotherapeutics​.

Rather it consisted of several separate installations of technologies. The facility houses technologies spanning the full range of upstream and downstream bioprocessing operations.


Single-use technologies are core to the plant according to the GE spokeswoman.

She told us: “FujiFilm Diosynth have been early adopters of single-use technologies, so they had experience and confidence running a single-use facility and its production processes. As a result, GE helped FujiFilm Diosynth to design their new facility around single-use technologies​.”

Related news

Show more

Related products

show more

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 20-Jan-2020 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...


Inline concentration improves process economics

Pall Biotech | 15-Jun-2018 | Case Study

Would you like to enhance your downstream process, increase production capacity and reduce costs? This case study application note demonstrates how implementing...

Related suppliers

Follow us


View more